Literature DB >> 11133262

The role of uric acid in protection against peroxynitrite-mediated pathology.

G S Scott1, D C Hooper.   

Abstract

Peroxynitrite, the product of the free radicals nitric oxide and superoxide, has been implicated in the pathogenesis of inflammatory CNS disorders. Uric acid, an effective scavenger of peroxynitrite, is a purine metabolite present at high levels in the serum of hominoids relative to lower-order animals due to the functional deletion of urate oxidase. Raising the normally low levels of uric acid in mice is therapeutic for experimental allergic encephalomyelitis, an animal model of multiple sclerosis. This therapeutic activity of uric acid is associated with the inhibition of peroxynitrite-induced tissue damage, blood-CNS barrier permeability changes, and CNS inflammation. Based on these findings we have concluded that peroxynitrite has an important role in promoting enhanced vascular permeability and inflammatory cell extravasation. We hypothesize that higher uric acid levels in hominoids evolved to protect against this process.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11133262     DOI: 10.1054/mehy.2000.1118

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  26 in total

Review 1.  Administration of Uric Acid in the Emergency Treatment of Acute Ischemic Stroke.

Authors:  Laura Llull; Sergio Amaro; Ángel Chamorro
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

2.  Uric acid enhances longevity and endurance and protects the brain against ischemia.

Authors:  Roy G Cutler; Simonetta Camandola; Neil H Feldman; Jeong Seon Yoon; James B Haran; Sandro Arguelles; Mark P Mattson
Journal:  Neurobiol Aging       Date:  2018-12-12       Impact factor: 4.673

3.  Therapeutic immune clearance of rabies virus from the CNS.

Authors:  D Craig Hooper; Anirban Roy; Rhonda B Kean; Timothy W Phares; Darryll A Barkhouse
Journal:  Future Virol       Date:  2011-03-01       Impact factor: 1.831

4.  Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity.

Authors:  Marzena J Fabis; Timothy W Phares; Rhonda B Kean; Hilary Koprowski; D Craig Hooper
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-30       Impact factor: 11.205

5.  Inosine protects against the development of diabetes in multiple-low-dose streptozotocin and nonobese diabetic mouse models of type 1 diabetes.

Authors:  Jon G Mabley; Alex Rabinovitch; Wilma Suarez-Pinzon; György Haskó; Pál Pacher; Robert Power; Gary Southan; Andrew Salzman; Csaba Szabó
Journal:  Mol Med       Date:  2003 Mar-Apr       Impact factor: 6.354

6.  Association of serum bilirubin and uric acid levels changes during neuroinflammation in patients with initial and relapsed demyelination attacks.

Authors:  Srdjan Ljubisavljevic; Ivana Stojanovic; Slobodan Vojinovic; Maja Milojkovic; Olivera Dunjic; Dragan Stojanov; Dusica Pavlovic
Journal:  Metab Brain Dis       Date:  2013-04-23       Impact factor: 3.584

7.  Understanding peroxynitrite biochemistry and its potential for treating human diseases.

Authors:  Joseph S Beckman
Journal:  Arch Biochem Biophys       Date:  2009-04-15       Impact factor: 4.013

8.  Peroxynitrite mediates glomerular lesion of diabetic rat via JAK/STAT signaling pathway.

Authors:  H Wang; Y Li; H Liu; S Liu; Q Liu; X M Wang; Y Shi; H Duan
Journal:  J Endocrinol Invest       Date:  2009-07-28       Impact factor: 4.256

9.  Uric acid as a CNS antioxidant.

Authors:  Gene L Bowman; Jackilen Shannon; Balz Frei; Jeffrey A Kaye; Joseph F Quinn
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

10.  Plasma urate and risk of Parkinson's disease.

Authors:  M G Weisskopf; E O'Reilly; H Chen; M A Schwarzschild; A Ascherio
Journal:  Am J Epidemiol       Date:  2007-06-20       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.